By Kamol Ismailov

Copyright trend

TASHKENT, Uzbekistan, October 8. Director of
the Agency for the Development of the Pharmaceutical Industry,
Abdulla Azizov, held a meeting with Wang Jun, Chairman of Guoju
Medical Technology, and Qiang Tie, President of the Tianjin
Shenlong Herb Medicine Traditional Chinese Medicine Health Research
Institute, to discuss the implementation of a pharmaceutical
project in Uzbekistan and the presentation of a detailed roadmap
for its stages and timelines, Trend reports.

During the discussions, the parties reviewed the implementation
of the project in the Jizzakh region, as well as opportunities for
establishing the production of pharmaceuticals and dietary
supplements (BAS) based on medicinal plants cultivated in
Uzbekistan.

Chinese investors plan, in the first phase, to establish a
research and laboratory complex for conducting studies and
developing new medicines (R&D). In addition, the company
intends to initiate scientific collaboration with the Institute of
Bioorganic Chemistry of the Academy of Sciences of Uzbekistan. The
second phase of the project envisions the organization of
production of finished pharmaceuticals based on the conducted

Following the meeting, the parties agreed to continue
cooperation and explore the possibility of locating laboratory and
production facilities within the Tashkent Pharma Park cluster, as
well as allocating land plots for cultivating medicinal plants in
the country. The Chinese side will present a “roadmap” outlining
the project’s implementation stages, timelines, and areas of

Meanwhile, bilateral trade between Uzbekistan and China
continues to grow rapidly. In the previous fiscal year, trade
exceeded $14 billion, reflecting a 23 percent increase since the
beginning of 2025. This robust growth highlights the deepening
economic ties between the two countries and underscores China’s
role as one of Uzbekistan’s most important and reliable

Stay up-to-date with more news on Trend News
Agency’s WhatsApp channel